{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:20:47Z","timestamp":1790626847757,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.cellimm.2018.01.011","type":"journal-article","created":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T21:14:45Z","timestamp":1516137285000},"page":"21-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["CD21-independent Epstein-Barr virus entry into NK cells"],"prefix":"10.1016","volume":"327","author":[{"given":"Jeong Hoo","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jahyang","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Oon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Seog","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2018.01.011_b0005","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40\u202fyears on","volume":"4","author":"Young","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellimm.2018.01.011_b0010","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1182\/blood-2008-07-077982","article-title":"Classification of lymphoid neoplasms: the microscope as a tool for disease discovery","volume":"112","author":"Jaffe","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2018.01.011_b0015","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/blood-2003-05-1401","article-title":"Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index","volume":"103","author":"Chim","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2018.01.011_b0020","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0037-1963(03)00136-7","article-title":"Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas\/leukemias","volume":"40","author":"Cheung","year":"2003","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.cellimm.2018.01.011_b0025","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/modpathol.3800369","article-title":"Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils","volume":"18","author":"Hudnall","year":"2005","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.cellimm.2018.01.011_b0030","doi-asserted-by":"crossref","first-page":"11139","DOI":"10.1128\/JVI.76.21.11139-11142.2002","article-title":"Evidence for early infection of nonneoplastic natural killer cells by Epstein-Barr virus","volume":"76","author":"Trempat","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.cellimm.2018.01.011_b0035","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.4049\/jimmunol.1302068","article-title":"Exosomes derived from Burkitt's lymphoma cell lines induce proliferation, differentiation, and class-switch recombination in B cells","volume":"192","author":"Gutzeit","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2018.01.011_b0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.canlet.2013.05.012","article-title":"Exosomes released in vitro from Epstein-Barr virus (EBV)-infected cells contain EBV-encoded latent phase mRNAs","volume":"337","author":"Canitano","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellimm.2018.01.011_b0045","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1615\/CritRevImmunol.v29.i3.20","article-title":"Exosome release by primary B cells","volume":"29","author":"McLellan","year":"2009","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2018.01.011_b0050","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nri855","article-title":"Exosomes: composition, biogenesis and function","volume":"2","author":"Thery","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2018.01.011_b0055","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.addr.2012.06.011","article-title":"Exosomes as nucleic acid nanocarriers","volume":"65","author":"van den Boorn","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.cellimm.2018.01.011_b0060","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cellimm.2018.01.011_b0065","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.4049\/jimmunol.170.12.5993","article-title":"Acquisition of viral receptor by NK cells through immunological synapse","volume":"170","author":"Tabiasco","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2018.01.011_b0070","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/ni0903-815","article-title":"What is trogocytosis and what is its purpose?","volume":"4","author":"Joly","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2018.01.011_b0075","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1074-7613(00)00049-2","article-title":"The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell","volume":"13","author":"Babcock","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2018.01.011_b0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/(SICI)1099-1654(200003\/04)10:2<83::AID-RMV262>3.0.CO;2-T","article-title":"EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus","volume":"10","author":"Leight","year":"2000","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.cellimm.2018.01.011_b0085","doi-asserted-by":"crossref","first-page":"10989","DOI":"10.1073\/pnas.1832776100","article-title":"The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold","volume":"100","author":"Humme","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cellimm.2018.01.011_b0090","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1073\/pnas.0810619106","article-title":"The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species","volume":"106","author":"Gruhne","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cellimm.2018.01.011_b0095","doi-asserted-by":"crossref","first-page":"14269","DOI":"10.1073\/pnas.2336099100","article-title":"Epstein-Barr virus provides a survival factor to Burkitt's lymphomas","volume":"100","author":"Kennedy","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cellimm.2018.01.011_b0100","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/0092-8674(91)90007-L","article-title":"Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death","volume":"65","author":"Henderson","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.cellimm.2018.01.011_b0105","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1128\/JVI.78.4.1697-1705.2004","article-title":"Latent membrane protein 2A inhibits transforming growth factor-beta 1-induced apoptosis through the phosphatidylinositol 3-kinase\/Akt pathway","volume":"78","author":"Fukuda","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.cellimm.2018.01.011_b0110","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/emboj\/21.5.954","article-title":"Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma","volume":"21","author":"Nanbo","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.cellimm.2018.01.011_b0115","doi-asserted-by":"crossref","first-page":"11236","DOI":"10.1128\/JVI.00579-07","article-title":"Epstein-Barr virus (EBV)-encoded RNA 2 (EBER2) but not EBER1 plays a critical role in EBV-induced B-cell growth transformation","volume":"81","author":"Wu","year":"2007","journal-title":"J. Virol."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000887491830011X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000887491830011X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T22:56:28Z","timestamp":1757804188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000887491830011X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":23,"alternative-id":["S000887491830011X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2018.01.011","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD21-independent Epstein-Barr virus entry into NK cells","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2018.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}